Research and Development

Showing 15 posts of 9604 posts found.

janssen_latest_logo_on_sign_closer

100% of multiple myeloma patients respond to Janssen’s investigational CAR T therapy, data shows

May 14, 2020 Research and Development CAR T, CAR-T, Janssen, multiple myeloma, pharma

Janssen has revealed new Phase1b/2 findings of the efficacy of its investigational B-cell maturation antigen (BCMA)-directed chimeric antigen receptor T cell …
fda

FDA grants Fast Track designation for Moderna’s coronavirus vaccine candidate

May 13, 2020 Research and Development COVID-19, coronavirs

The FDA has granted Fast Track designation for Moderna Inc’s mRNA vaccine candidate against the coronavirus. The regulatory body had …
researcherssss

AMAG Pharmaceuticals to cut 30% of staff as part of restructure

May 13, 2020 Research and Development COVID-19, coronavirus

AMAG Pharmaceuticals announced that it will cut 30% of its staff, or 140 jobs, as part of a companywide restructuring. …
generics

Gilead signs deal with generic drugmakers to expand global supply of remdesivir

May 13, 2020 Research and Development COVID-19, coronavirus, remdesivir

Gilead Sciences has signed an exclusive licensing agreement with five generics drug companies in India and Pakistan to supply them …
coroanrvisu_cdc

Pharmafile.com’s weekly COVID-19 news round-up

May 13, 2020 Research and Development COVID-19, coronavirus

Developments in treatments for COVID-19 continue to dominate the news as the latest in hydroxychloroquine trials shows it does not …
trialsssssss

Researchers in Denmark testing if senicapoc drug can reduce lung damage in COVID-19 patients

May 13, 2020 Research and Development COVID-19, Sars, coronavirus

Scientists are studying if senicapoc, a treatment for sickle cell anemia, can be repurposed to mitigate damage to a COVID-19 …
korea_govt

South Korea says Ebola drug remdesivir may not be suitable for all coronavirus patients

May 6, 2020 Research and Development COVID-19, coronavirus, south korea

South Korea says that remdesivir, traditionally used in treating Ebola, may not be effective enough in treating COVID-19 patients. South …
fda2outsideweb

AZ’s Farxiga becomes first FDA-approved SGLT2 inhibitor for heart failure with reduced ejection fraction

May 6, 2020 Research and Development, Sales and Marketing AstraZeneca, FDA, farxiga, heart failure

The FDA has moved to approve an oral tablet formulation of AstraZeneca’s Farxiga (dapagliflozin) to reduce the risk of cardiovascular …
partnership

Portola Pharmaceuticals to merge with Alexion in $1.41bn cash deal

May 6, 2020 Research and Development, Sales and Marketing Alexion, Portola Pharmaceuticals, pharma

Alexion has announced it is to acquire Boston-based blood disorder specialist Portola Pharmaceuticals in a transaction to the value of …
coroanrvisu_cdc

Pharmafile.com’s weekly COVID-19 news round-up

May 6, 2020 Research and Development COVID-19, coronavirus

Vaccines and treatments for COVID-19 continue to dominate the news, as two studies reveal “positive” data for Gilead’s remdesivir in …
trumpppppp

Ousted chief of BARDA says Trump administration ignored COVID-19 warnings

May 6, 2020 Research and Development BARDA, COVID-19, chloroquine, coronavirus, hydroxychloroquine

Ousted Director of the Biomedical Advanced Research and Development Authority (BARDA), Dr Rick Bright, alleges the Trump administration ignored warnings …
s300_yellow-card-govuk960

MHRA launches new pharmacovigilance reporting platform for COVID-19 treatments

May 5, 2020 Manufacturing and Production, Research and Development COVID-19, MHRA, UK, coronavirus, pharma

A new online reporting site has been launched by the Medicines and Healthcare products Regulatory Agency’s (MHRA) to track potential …
shutter

Sanofi and Regeneron’s Libtayo shows durable responses in world’s most common skin cancer

May 5, 2020 Manufacturing and Production, Research and Development Cancer, Libtayo, Regeneron, Sanofi

Sanofi and Regeneron’s have lifted the lid on new topline data on their PD-1 inhibitor Libtayo (cemiplimab) in patients with …
kim_stratton_orphazyme

Working Life Interview: Kim Stratton, CEO, Orphazyme

May 4, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interview, Orphazyme, Working Life

“Every professional faces challenges. As a woman in industry, particularly in leadership, it adds another dimension to those challenges in …
The Gateway to Local Adoption Series

Latest content